Current perspectives on targeting PIM kinases to overcome mechanisms of drug resistance and immune evasion in cancer
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference172 articles.
1. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc;Allen;Oncogene,1997
2. Myc and the cell cycle;Amati;Frontiers in Bioscience,1998
3. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias;Amson;Proceedings of the National Academy of Sciences of the United States of America,1989
4. A review on PIM kinases in tumors;Arrouchi;Bioinformation,2019
5. Re-positioning of known drugs for Pim-1 kinase target using molecular docking analysis;Arrouchi;Bioinformation,2019
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PIM1 kinase promotes EMT-associated osimertinib resistance via regulating GSK3β signaling pathway in EGFR-mutant non-small cell lung cancer;Cell Death & Disease;2024-09-03
2. PIM kinase inhibitors: an updated patent review (2016-present);Expert Opinion on Therapeutic Patents;2024-05-03
3. Melasolv™: a potential preventive and depigmenting agent for the senescence of melanocytes;Frontiers in Molecular Biosciences;2024-01-04
4. Acetylation and Phosphorylation in the Regulation of Hypoxia-Inducible Factor Activities: Additional Options to Modulate Adaptations to Changes in Oxygen Levels;Life;2023-12-21
5. PIM kinases regulate early human Th17 cell differentiation;Cell Reports;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3